abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition,differing by the fact that a nanocapsule core is aspirin, and a coating is sodium alginate deposited from butanol suspension by adding carbon tetrachloride as a non-solvent and water that is followed by drying at room temperature. n EFFECT: invention provides simplifying and accelerating the nanoencapsulation process, reducing accompanying loss (higher weight yield). n 3 ex |